GSK plc
- SEC CIK
- 0001131399
- Latest filing
- Aug 13, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 13, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 13
- 0 vs. Q1 2026
- Portfolio value
- $602.2M
- +$3.07M (+0.5%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 3,220,627 | $175.7M | 29.2% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 18,245,691 | $106.0M | 17.6% | 00.0% | Unchanged | History |
| VIRVir Biotechnology, Inc. | COM | 8,550,954 | $87.1M | 14.5% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 889,824 | $82.8M | 13.7% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,333,333 | $49.7M | 8.3% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 340,434 | $29.0M | 4.8% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 1,512,659 | $21.3M | 3.5% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 9,190,606 | $20.3M | 3.4% | 00.0% | Unchanged | History |
| NKTXNkarta, Inc. | COM | 3,150,732 | $8.92M | 1.5% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,785,714 | $6.54M | 1.1% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,529,561 | $6.49M | 1.1% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 1,007,583 | $5.18M | 0.9% | 00.0% | Unchanged | History |
| RGNXREGENXBIO Inc. | COM | 271,456 | $3.25M | 0.5% | 00.0% | Unchanged | History |